DARE BIOSCIENCE INC stock forecast: down to 0.35 USD DARE stock price prognosis

STOCK

Forecast for Fri 21 Jun 2024 price 0.43

DARE BIOSCIENCE INC stock price forecast for further price development down to -32.02% (time horizon: 1 day) and price target of 0.35 USD. Short-term (time horizon: 2 weeks) DARE BIOSCIENCE INC share price prediction for 2024-06-21 with daily closed price projections

Key Facts

Symbol DARE 

ISIN US23666P1012 

CUSIP 23666P101


Currency USD


Category Pharmaceutical Preparations

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Earnings per share -0.91


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Of the 28 evaluable subjects, 24, or 86%, achieved clinical cure at Visit 2. The following is a summary of other terms of the Catalent license agreement:Upfront Fee. Some nonclinical testing may continue after the IND is submitted. The three phases are as follows:Phase 1. Premarket notifications are subject to user fees, unless a specific exemption applies. The federal Anti-Kickback Statute is subject to evolving interpretations. A decision from the Supreme Court is expected to be issued in spring 2021. However, overall related timelines will be defined by the Clinical Trials Regulation. EmployeesAs of March 29, 2021, we had 23 employees. We and our wholly-owned subsidiaries operate in one business segment. We may never become profitable. We may realize only a small fraction of the potential value of the license agreement. There can be no assurance that we can raise additional capital when needed. We also expect to face competition from new products that enter the market. We depend highly on our senior management. Moreover, if and when we become an accelerated filer, our compliance costs will increase. A failure of one or more clinical trials could occur at any stage of testing. BUSINESS-Overview-License Agreements-SST License and Collaboration Agreement," above. This could significantly lengthen our development timelines and cost. Today, there are no FDA-approved products to treat FSAD. As a result, it may be difficult for us to fund such programs. We refer to this agreement as our "Purchase Agreement." We do not have any control over these analysts.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1401914/000140191421000041/0001401914-21-000041.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 13.02/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-11-30 97011 Long
Fidelity Concord Street Trust 2023-11-30 186895 Long
Fidelity Concord Street Trust 2023-11-30 29994 Long
Fidelity Concord Street Trust 2023-11-30 446551 Long
Victory Portfolios III 2023-10-31 9509 Long


Bollinger Bollinger Bands for DARE BIOSCIENCE INC can provide the information where the market is moving based on price information.


DARE BIOSCIENCE INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns DARE BIOSCIENCE INC.


On-Balance Volume information for DARE BIOSCIENCE INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for DARE BIOSCIENCE INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for DARE BIOSCIENCE INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for DARE BIOSCIENCE INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for DARE BIOSCIENCE INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for DARE BIOSCIENCE INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for DARE BIOSCIENCE INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


Moving Average Crossover


52W High 52W Low Market Cap

Similar shares


DARE BIOSCIENCE INC on Nasdaq

DARE BIOSCIENCE INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-22 0.35 2024-04-26 13:03
2024-05-24 0.36 2024-04-26 13:03
2024-05-23 0.35 2024-04-26 13:03
2024-05-20 0.34 2024-04-26 13:03
2024-05-21 0.35 2024-04-26 13:03
2024-05-27 0.36 2024-04-26 13:03
2024-05-28 0.37 2024-04-26 13:03
2024-05-29 0.37 2024-04-26 13:03
2024-05-30 0.37 2024-04-26 13:03
2024-06-05 0.39 2024-04-26 13:03
2024-06-07 0.39 2024-04-26 13:03
2024-06-03 0.38 2024-04-26 13:03
2024-06-04 0.38 2024-04-26 13:03
2024-05-31 0.38 2024-04-26 13:03
2024-06-06 0.39 2024-04-26 13:03
2024-06-10 0.40 2024-04-26 13:03
2024-06-11 0.40 2024-04-26 13:03
2024-06-12 0.40 2024-04-26 13:03
2024-06-13 0.41 2024-04-26 13:03
2024-06-17 0.41 2024-04-26 13:03
2024-06-18 0.42 2024-04-26 13:03
2024-06-19 0.42 2024-04-26 13:03
2024-06-14 0.41 2024-04-26 13:03
2024-06-20 0.42 2024-04-26 13:03
2024-06-21 0.43 2024-04-26 13:03
2024-05-13 0.32 2024-04-26 13:03
2024-05-14 0.34 2024-04-26 13:03
2024-05-15 0.33 2024-04-26 13:03
2024-05-16 0.33 2024-04-26 13:03
2024-04-29 0.30 2024-04-26 13:03
2024-04-30 0.30 2024-04-26 13:03
2024-05-01 0.32 2024-04-26 13:03
2024-05-03 0.32 2024-04-26 13:03
2024-05-08 0.33 2024-04-26 13:03
2024-05-09 0.33 2024-04-26 13:03
2024-05-17 0.34 2024-04-26 13:03
2024-05-02 0.32 2024-04-26 13:03
2024-05-06 0.32 2024-04-26 13:03
2024-05-07 0.32 2024-04-26 13:03
2024-05-10 0.34 2024-04-26 13:03

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.